AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 ,inter alia, to consider and approve This is with reference to our letter dated 19th January 2024, informing about the Board meeting scheduled on Wednesday, 31st January 2024 to inter-alia consider and take on record the unaudited financial results for the third quarter ended 31st December 2023. Pursuant to Regulation 29(1)(e) of the Listing Regulations, we hereby inform that, at the aforesaid Board Meeting, the Board of Directors will also consider: a. declaration of 2nd interim dividend for the financial year ending 31st March 2024; b. fixation of Thursday, 8th Dec 2024 as the Record Date for the payment of 2nd interim dividend, if declared.